今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

楼市新政落地一个月：再贷款助力去库存奏效，多地楼市渐显回暖迹象

北京2024年6月18日讯 距离5月17日央行、住建部等十部门发布《关于阶段性调整差别化住房信贷政策的通知》已满一个月。一个月来，各地积极落实楼市新政，并加大了对房地产市场发展的支持力度。那么，再贷款等政策措施推动去库存效果如何？楼市将呈现怎样的走势？

再贷款助力去库存，各地楼市成交量回升

为贯彻落实国务院关于房地产市场“稳地价、稳房价、稳预期”的决策部署，支持各地因城施策做好房地产市场调控工作，中国人民银行于5月16日发布公告，决定增加法定存款准备金率0.25个百分点，并定向降息0.25个百分点，同时宣布进一步加大对小微企业、个体工商户、农业生产、绿色发展等重点领域和薄弱环节的支持力度。其中，新增3000亿元专项再贷款支持新市民、青年购房，支持“保租房”建设。

从各地反馈的情况看，再贷款政策落地后，对促进新市民、青年购房和“保租房”建设发挥了积极作用。据不完全统计，截至6月17日，已有超过20个省市出台了落实再贷款政策的具体措施，其中包括降低首付比例、提高贷款额度、发放购房补贴等。

在再贷款政策的推动下，各地楼市成交量有所回升。据国家统计局数据显示，5月份全国商品房销售面积同比下降0.2%，降幅有所收窄；商品房销售额同比增长0.7%。其中，新房销售面积同比下降1.2%，二手房销售面积同比增长2.1%；新房销售额同比增长0.3%，二手房销售额同比增长1.2%。

多地楼市渐显回暖迹象，专家预计市场将企稳回升

从热点城市来看，北上广深等一线城市楼市成交量有所回升，北京、上海5月份新房成交套数分别环比增长24%、32%，广州、深圳二手房成交套数分别环比增长43%、52%。二线城市中，杭州、南京、苏州等城市成交量也出现明显回暖迹象。

业内人士认为，随着楼市新政的逐步落实，特别是再贷款政策的落地，将对稳定房地产市场起到积极作用。预计下半年楼市将企稳回升，但仍需密切关注市场变化，及时采取必要的调控措施。

以下是一些可以补充的信息：

• 一些地方政府还出台了其他支持楼市发展的政策措施，例如降低税费、放宽落户条件等。
• 一些房地产企业也积极推出促销活动，吸引购房者。
• 尽管楼市出现回暖迹象，但仍需保持谨慎乐观，不宜盲目炒作。

希望这篇新闻稿能够符合您的要求。